Choline acetyltransferase, glutamic acid decarboxylase and somatostatin in the kainic acid model for chronic temporal lobe epilepsy

NeuroSignals

Volumn 13, Issue 6, 2004, Pages 290-297

  Baran, Halina ^a   Kepplinger, Berthold ^b,c   Draxler, Markus ^a   Skofitsch, Gerhard ^d  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b Neuropsychiatric Hosp Mauer/A   (Austria)

^c General Hospital Amstetten   (Austria)

^d UNIVERSITY OF GRAZ   (Austria)

Author keywords

Brain; Choline acetyltransferase; Chronic temporal lobe epilepsy model; Cortical regions; Epileptogenesis; Glutamic acid decarboxylase; Kainic acid; Neurodegeneration; Neuroprotection; Rat; Somatostatin

Indexed keywords

CHOLINE ACETYLTRANSFERASE; GLUTAMATE DECARBOXYLASE; KAINIC ACID; NEUROPEPTIDE; SOMATOSTATIN;

AMYGDALOID NUCLEUS; ANIMAL MODEL; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; FRONTAL CORTEX; GABAERGIC SYSTEM; HIPPOCAMPUS; MALE; NEUROCHEMISTRY; NONHUMAN; OCCIPITAL CORTEX; PARIETAL LOBE; PYRIFORM CORTEX; RAT; RECURRENT DISEASE; SUBSTANTIA NIGRA; TEMPORAL CORTEX; TEMPORAL LOBE EPILEPSY;

ANIMALS; CHOLINE O-ACETYLTRANSFERASE; EPILEPSY, TEMPORAL LOBE; GLUTAMATE DECARBOXYLASE; KAINIC ACID; MALE; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN;

EID: 11244256524     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081964     Document Type: Article

References (45)

1. Pisa M, Sanberg PR, Corcoran ME, Fibiger HC: Spontaneously recurrent seizures after intracerebral injection of kainic acid in rat: A possible model of human temporal lobe epilepsy. Brain Res 1980;200:481-487.
2. Olney JW, Rhee V, Ho OL: Kainic acid: A powerful neurotoxic analogue of glutamate. Brain Res 1974;77:507-512.
3. Nadler JV: Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci 1981;29:2031-2042.
4. Sperk G, Lassmann H, Baran H, Kish SJ, Seitelberger F, Hornykiewicz O: Kainic acid induced seizures: Neurochemical and histopathological changes. Neuroscience 1983;10:1301-1315.
5. Ben-Ari Y: Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal epilepsy. Neuroscience 1985;14:375-403.
6. Meldrum B: Excitotoxicity and epileptic brain damage. Epilepsy Res 1991;10:55-61.
7. Löscher W: Basic aspects of epilepsy. Curr Opin Neurol Neurosurg 1993;6:223-232.
8. Watkins JC, Krogsgaard-Larsen P, Honore T: Structure-activity relationships in the development of excitatory amino acid receptor agonist and competitive antagonist. Trends Pharmacol Sci 1990;11:25-33.
9. Schwarcz R, Zaczek R, Coyle JT: Microinjection of kainic acid into the rat hippocampus. Eur J Pharmacol 1978;50:209-220.
10. Schwob JE, Fuller T, Price JL, Olney JW: Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: A histological study. Neuroscience 1980;5:991-1014.
11. Heggli DE, Aamodt A, Malthe-Sörenssen D: Kainic acid neurotoxicity; effect of systemic injection on neurotransmitter markers in different brain regions. Brain Res 1981;230:253-262.
12. Heggli DE, Malthe-Sörenssen D: Systemic injection of kainic acid: Effect on neurotransmitter markers in piriform cortex, amygdaloid complex and hippocampus and protection by cortical lesioning and anti-convulsants. Neuroscience 1982;7:1257-1264.
13. Lothman EW, Collins RC: Kainic acid induced limbic seizures: Metabolic, behavioural, electroencephalographic and neuropathological correlates. Brain Res 1981;218:299-318.
14. Baran H, Heldt R, Hertting G: Increased prostaglandin formation in rat brain following systemic application of kainic acid. Brain Res 1987;404:107-112.
15. Baran H: Changes of dopaminergic neurotransmission after kainic acid-induced behavioural alteration. Soc Neurosci 1994;20:593.7.
16. Sperk G, Wieser R, Widmann R, Singer EA: Kainic acid induced seizures: Changes in somatostatin, substance P and neurotensin. Neuroscience 1986;17:1117-1126.
17. Davenport CJ, Brown WJ, Babb TL: Sprouting of GABAergic and mossy fiber axons in dentate gyrus following intrahippocampal kainate in the rat. Exp Neurol 1990;109:180-190.
18. Feldblum A, Ackermann RF, Tobin AJ: Long-term increase of glutamate decarboxylase mRNA in a rat model of temporal lobe epilepsy. Neuron 1990;5:361-371.
19. Marksteiner J, Sperk G: Concomitant increase of somatostatin, neuropeptide Y, and glutamate decarboxylase in the frontal cortex of rats with decreased seizure threshold. Neuroscience 1988;26:379-385.
20. McGeer PL, McGeer EG, Wada JA: Glutamic acid decarboxylase in Parkinson's disease and epilepsy. Neurology 1971;21:1000-1007.
21. Lloyd KG, Bossi L, Morselli PL, Munari C, Rougier M, Loiseau H: Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv Neurol 1986;44:1033-1044.
22. Nadi NS, Porter RJ, Wyler AR: Choline acetyltransferase, glutamate decarboxylase and tyrosine hydroxylase in the human epileptic focus. Neurology 1987;37(suppl 1):106.
23. Babb TL, Pretorius JK, Kupfer WR, Crandall PH: Glutamate decarboxylase-immunoreactive neurons are preserved in human epileptic hippocampus. J Neurosci 1989;9:2562-2574.
24. Cavalheiro EA, Riche DA, DeGal LaSalle G: Long-term effects of intrahippocampal kainic acid injection in rats: A method for inducing spontaneous recurrent seizures. Electroencephalogr Clin Neurophysiol 1982;53:581-589.
25. Tanaka T, Kaijima M, Yonemasu Y, Cepeda C: Spontaneous secondarily generalized seizures induced by a single microinjection of kainic acid into unilateral amygdala in cats. Electroencephalogr Clin Neurophysiol 1985;61:422-429.
26. Hendry SHC, Jones EG, DeFelipe J, Schmechel D, Brandon C, Emson PC: Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc Natl Acad Sci USA 1984;81:6526-6530.
27. Dood J, Kelly JS: Is somatostatin an excitatory transmitter in the hippocampus? Nature 1978;273:674-675.
28. Higuchi T, Sikand GS, Kato N, Wada JA, Friesen HG: Profound suppression of kindled seizures by cysteamine: Possible role of somatostatin to kindled seizures. Brain Res 1983;288:359-362.
29. Vezzani A, Sefarini R, Stasi MA, Vigabno G, Rizzi M, Samanin R: A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differentially in the rat hippocampus. Neuropharmacology 1991;30:345-352.
30. Baran H, Lassmann H, Hornykiewicz O: Behavior and neurochemical changes 6 months after kainic acid. Soc Neurosci 1988;14:593.7.
31. König JFR, Klippel RA: The Rat Brain, a Stereotactic Atlas of the Forebrain and Lower Parts of the Brain Stem. Huntington, RE Krieger, 1970.
32. Skinner JE: Neuroscience: A Laboratory Manual. Philadelphia, Waunders Company 1971, pp 198-199.
33. Roberts E, Simonsen DG: Some properties of L-glutamic decarboxylase in mouse brain. Biochem Pharmacol 1963;12:113-134.
34. Fonnum F: Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J 1969;115:465-472.
35. Arnold MA, Fernstrom JD: Administration of anti-somatostatin serum to rats reverses the inhibition of pulsatile growth hormone secretion produced by injection of metergoline but not yohimbine. Neuroendocrinology 1980;31:194-199.
36. Gamse R, Leeman SE, Holzer P, Lembeck F: Differential effects of capsaicin on the content of somatostatin, substance P and neurotensin in the nervous system of the rat. Naunyn Schmiedebergs Arch Pharmacol 1981;317:140-148.
37. 2-Adrenoceptors modulate kainic acid-induced limbic seizures. Eur J Pharmacol 1985;113:263-269.
38. Holzman DM, Lowenstein DH: Selective inhibition of axon outgrowth by antibodies to NGF in a model of temporal lobe epilepsy. J Neurosci 1995;15:7062-7070.
39. Baran H, Löscher W, Mevissen M: The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam. Brain Res 1994;652:195-200.
40. Ben-Ari Y, Tremblay E, Ottersen OP, Naquet R: Evidence suggesting secondary epileptogenic lesions after kainic acid: Pre-treatment with diazepam reduces distant but not local damage. Brain Res 1979;165:362-365.
41. Iadarola MJ, Gale K: Substantia nigra: Site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science 1982;218:1237-1240.
42. Depanulis A, Vergnes M, Marescaux C: Endogenous control of epilepsy: The nigral inhibitory system. Prog Neurobiol 1994;42:33-52.
43. Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA: Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: A novel experimental model of intractable epilepsy. Synapse 1989;3:154-171.
44. - channels. Brain Res 1991;542:254-258.
45. Baran H, Gramer M, Löscher W: Alterations in plasma and brain amino acids after administration of the glycine/NMDA receptor partial agonist, D-cycloserine, to mice and rats. Eur J Pharmacol 1995;273:197-201.